Corporate Banner
Satellite Banner
qPCR
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Aravis Strengthens Life Science Team with Three Important Appointments

Published: Friday, January 10, 2014
Last Updated: Thursday, January 09, 2014
Bookmark and Share
Dr Dani Bach (formerly of Index Ventures) joins as Managing Partner, Dr Jacques Mizrahi joins in a consulting role as Venture Partner and Kadri Vunder (formerly LSVenture) as a Partner.

Aravis has announced the appointment of three new members of the life science investment team.

Dr Dani Bach joins Aravis in February 2014 as Managing Partner within the life science team. Dani was previously part of the life sciences team at Geneva based venture fund, Index Ventures, having joined the firm in 2007.

Dani’s investment interests have focused on protein therapeutics, neurodegeneration, and medical devices. Prior to joining Index, Dani held a research position at the Ecole Polytechnique Federal de Lausanne (EPFL), where he worked on the complex interactions between human immunodeficiency virus (HIV) and the human immune system. Dani holds a PhD in Molecular Biology from the University of Barcelona.

Dr Jacques Mizrahi began consulting Aravis as a Venture Partner in mid-2013. Dr Mizrahi has over 20 years of experience in drug discovery, drug development and translational medicine for many large pharma companies including Roche where his last position was as an Executive Leader, Cardiovascular & Metabolic Diseases. He has a PhD in pharmacology from Sherbrooke University, Quebec Canada.

Dr Kadri Vunder joined Aravis’ life science team as a Partner mid-2013. Dr. Vunder has over 10 years investment and executive management experience in the biotech, chemical and financial industries. Prior to joining Aravis, Kadri built up and managed a biotechnology oriented seed investment firm LSVenture.

Kadri holds a PhD in Economics from the University of St. Gallen and scientific degrees from the Tallinn Technical University in Biotechnology and Analytical Chemistry.

Dr Simon Nebel, Founder and Managing Partner at Aravis said :“2014 will be an important year for us and we are excited to be starting it with the appointment of these high caliber team members. I am confident that their deep knowledge and proven expertise in the life science sector will be advantageous for Aravis’ future enterprises.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Lab-Tested Diagnosis Needed When Treating Persistent Diarrhea
New PCR multiplex method makes lab testing more effective.
Biomarker for Multiple Sclerosis Detection Discovered
Winthrop-University Hospital researchers discover biomarker for multiple sclerosis detection.
Scientists Link Bipolar Disorder to Unexpected Brain Region
Researchers from The Scripps Research Institute have found that gene within the brain’s striatum could be linked to biopolar disorder.
Quick, Early Test For Ebola Could Prevent Epidemics
Researchers from Princeton University are collaborating with U.S. government labs to develop a more rapid, accurate and inexpensive test for the Ebola virus with the aim of identifying infections before carriers become symptomatic and contagious.
From Super to Ultra-Resolution Microscopy
A new method pushes the frontier in imaging resolution, with the potential to distinguish individual features in single molecules.
Cancer Research UK joins forces with U.S. 'Cancer Moonshot'
Cancer Research UK and the US government’s National Cancer Institute have announced that two teams will work together to radically accelerate progress against cancer, in one of the first international collaborations inspired by US Vice President Joe Biden’s Cancer Moonshot.
Assessing the Effectiveness of Genome-Editing Technologies
Researchers have developed a cost-effective and rapid method for assessing edits generated by CRISPR-Cas9 and other genome-editing technologies.
Measuring the Abundance of Extremely Rare Mutations
Researchers from Rutgers University demonstrate the use of multiplex real-time PCR assays to measure the abundance of extremely rare mutations associated with cancer.
Harnessing Helpful Microbes
Seeking to further harness microbes’ many uses, the federal government has launched the National Microbiome Initiative (NMI) to “foster the integrated study of microbiomes across different ecosystems.”
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!